Malignant neoplasm of prostate
|
0.600 |
Biomarker
|
disease |
BEFREE |
The mail goal of this research was to study the functional role of Circ-ITCH gene in prostate cancer and to illuminate the function role of circ-ITCH gene in prostate cancer by targeting miR-17-5p/HOXB13.
|
31827402 |
2019 |
Prostate carcinoma
|
0.200 |
Biomarker
|
disease |
BEFREE |
The mail goal of this research was to study the functional role of Circ-ITCH gene in prostate cancer and to illuminate the function role of circ-ITCH gene in prostate cancer by targeting miR-17-5p/HOXB13.
|
31827402 |
2019 |
Malignant tumor of colon
|
0.120 |
Biomarker
|
disease |
BEFREE |
HOXB13 inhibited colon cancer cell proliferation and induced apoptosis both in vitro and in vivo.
|
31815008 |
2019 |
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
Tumor-suppressive function and mechanism of HOXB13 in right-sided colon cancer.
|
31815008 |
2019 |
Renal Cell Carcinoma
|
0.020 |
AlteredExpression
|
disease |
BEFREE |
Tissue sample analysis showed that HOXB13 was differentially expressed between normal and only RCC tumor tissues.
|
31815008 |
2019 |
Conventional (Clear Cell) Renal Cell Carcinoma
|
0.020 |
AlteredExpression
|
disease |
BEFREE |
Tissue sample analysis showed that HOXB13 was differentially expressed between normal and only RCC tumor tissues.
|
31815008 |
2019 |
Colon Carcinoma
|
0.020 |
Biomarker
|
disease |
BEFREE |
HOXB13 inhibited colon cancer cell proliferation and induced apoptosis both in vitro and in vivo.
|
31815008 |
2019 |
Refractory Cytopenia of Childhood
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
Tissue sample analysis showed that HOXB13 was differentially expressed between normal and only RCC tumor tissues.
|
31815008 |
2019 |
Prostatic Neoplasms
|
0.380 |
AlteredExpression
|
group |
BEFREE |
Partitioning the genome according to cistromes reveals the enrichment of somatic SNVs in prostate tumors as opposed to adjacent normal tissue cistromes of master transcription regulators, including AR, FOXA1, and HOXB13.
|
31735626 |
2019 |
Malignant neoplasm of prostate
|
0.600 |
GeneticVariation
|
disease |
BEFREE |
Updated insights into genetic contribution to prostate cancer predisposition: focus on HOXB13.
|
31629417 |
2019 |
Prostate carcinoma
|
0.200 |
GeneticVariation
|
disease |
BEFREE |
Updated insights into genetic contribution to prostate cancer predisposition: focus on HOXB13.
|
31629417 |
2019 |
Malignant neoplasm of prostate
|
0.600 |
Biomarker
|
disease |
BEFREE |
Unsupervised Principal Component Analysis (PCA) led to a focused core HOXB13 target gene-set referred to as HOTPAM9 (HOXB13 Targets separating Primary And Metastatic PCs).
|
31273254 |
2019 |
Prostatic Neoplasms
|
0.380 |
AlteredExpression
|
group |
BEFREE |
To identify HOXB13 transcriptional targets in metastatic PCs, we performed integrative bioinformatics analysis of differentially expressed genes (DEGs) in the proximity of the human prostate tumor-specific AR binding sites.
|
31273254 |
2019 |
Prostate carcinoma
|
0.200 |
Biomarker
|
disease |
BEFREE |
Unsupervised Principal Component Analysis (PCA) led to a focused core HOXB13 target gene-set referred to as HOTPAM9 (HOXB13 Targets separating Primary And Metastatic PCs).
|
31273254 |
2019 |
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
Collectively, our results indicate that HOXB13 promotes metastasis of PCs by coordinated regulation of mitotic kinases and blockade of a putative tumor suppressor gene.
|
31273254 |
2019 |
Neoplasm Metastasis
|
0.060 |
Biomarker
|
phenotype |
BEFREE |
Collectively, our results indicate that HOXB13 promotes metastasis of PCs by coordinated regulation of mitotic kinases and blockade of a putative tumor suppressor gene.
|
31273254 |
2019 |
Malignant neoplasm of prostate
|
0.600 |
GeneticVariation
|
disease |
BEFREE |
Association with PCa risk was statistically significant for variants in BRCA2 (P < 0.001, OR = 5.65, 95% CI = 3.55-9.32), HOXB13 (P < 0.001, OR = 4.73, 95% CI = 2.84-8.19), and ATM (P < 0.001, OR = 2.86, 95% CI = 1.63-5.15).
|
31214711 |
2019 |
Prostate carcinoma
|
0.200 |
GeneticVariation
|
disease |
BEFREE |
Association with PCa risk was statistically significant for variants in BRCA2 (P < 0.001, OR = 5.65, 95% CI = 3.55-9.32), HOXB13 (P < 0.001, OR = 4.73, 95% CI = 2.84-8.19), and ATM (P < 0.001, OR = 2.86, 95% CI = 1.63-5.15).
|
31214711 |
2019 |
Adenoid Cystic Carcinoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
Immunohistochemistry of protein expressions validated 4 upregulated genes (ODAM, HOXB13, MYB and SOX10) considered important and as potential biomarkers for spiradenomas and cylindromas.
|
31128548 |
2019 |
Eccrine spiradenoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
Immunohistochemistry of protein expressions validated 4 upregulated genes (ODAM, HOXB13, MYB and SOX10) considered important and as potential biomarkers for spiradenomas and cylindromas.
|
31128548 |
2019 |
Tumor Cell Invasion
|
0.070 |
Biomarker
|
phenotype |
BEFREE |
GBM cells U87 and U251 overexpressing HOXB13 showed enhanced proliferation, migration, and invasion relative to the control cells, while knockdown of HOXB13 led to decreased cell proliferation, migration, and invasion abilities.
|
31062400 |
2019 |
Glioblastoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
In summary, this study revealed the prognostic potential of HOXB13 in GBM.
|
31062400 |
2019 |
Adult Glioblastoma
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
HOXB13 promotes proliferation, migration, and invasion of glioblastoma through transcriptional upregulation of lncRNA HOXC-AS3.
|
31062400 |
2019 |
Childhood Glioblastoma
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
HOXB13 promotes proliferation, migration, and invasion of glioblastoma through transcriptional upregulation of lncRNA HOXC-AS3.
|
31062400 |
2019 |
Glioblastoma Multiforme
|
0.010 |
Biomarker
|
disease |
BEFREE |
In summary, this study revealed the prognostic potential of HOXB13 in GBM.
|
31062400 |
2019 |